Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. II. Subcellular localization of 99Tc-DMS complex in the rat kidney in vivo
- PMID: 6288382
- DOI: 10.1007/BF00253425
Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. II. Subcellular localization of 99Tc-DMS complex in the rat kidney in vivo
Abstract
In order to extend and confirm our previous studies of in vivo behaviour of 99mTc-DMS in rat kidney cells, the intracellular localization of 99Tc-DMS complex in rat kidney tissue was examined. Animals were injected IV with 99Tc-DMS solution (37 kbq in 1.0 ml) 2 h before killing. Dissected kidneys were homogenized and submitted to differential centrifugation to obtain organelles. The following radioactivity distribution in relation to the total radioactivity of homogenate was obtained in nine experiments: nuclei 3.30% (+/-1.27), mitochondria 9.48% (+/-2.17), microsomes 7.03% (+/-2.34) and cytosol 57.45% (+/-8.01). The subcellular distribution pattern of 99Tc-DMS was in very good agreement with the pattern of 99Tc-DMS binding to kidney cell organelles obtained by the same procedure. Soluble cytoplasmic proteins binding 99Tc-DMS were excluded from a Sephadex G-25 column with the void volume. Their electrophoretic mobility after agarose gel electrophoresis corresponded to beta-lc- and alpha-2-macroglobulins. The results obtained show unambiguously that the investigated complex penetrates into the kidney cells where it binds mostly to soluble cytoplasmic proteins and mitochondria, and to a lesser extent to both microsomes and nuclei. In another series of six experiments, isolated kidney cortical tissue was used, the same procedure was repeated and similar results were obtained.
Similar articles
-
Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. III. Subcellular distribution and interaction of 99Tc-DMS complex with macromolecules in rat kidney homogenates in vitro.Eur J Nucl Med. 1982;7(7):308-10. doi: 10.1007/BF00253426. Eur J Nucl Med. 1982. PMID: 6288383
-
Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. I. Subcellular localization of 99mTc-DMS complex in the rat kidney in vivo.Eur J Nucl Med. 1981 Apr;6(4):169-72. doi: 10.1007/BF00253168. Eur J Nucl Med. 1981. PMID: 6260501
-
Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. IV. Interaction of 99mTc-DMS and 99Tc-DMS complexes with blood serum proteins.Eur J Nucl Med. 1984;9(8):370-3. doi: 10.1007/BF00252873. Eur J Nucl Med. 1984. PMID: 6208030
-
Preparation of technetium-99-DMS renal complex in solution and its chemical and biological characterization.Int J Appl Radiat Isot. 1982 Apr;33(4):277-84. doi: 10.1016/0020-708x(82)90027-8. Int J Appl Radiat Isot. 1982. PMID: 6282761
-
The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent.Int J Nucl Med Biol. 1985;12(4):273-9. doi: 10.1016/0047-0740(85)90180-9. Int J Nucl Med Biol. 1985. PMID: 3002999
Cited by
-
99m-Technetium binding site in bone marrow mononuclear cells.Stem Cell Res Ther. 2015 Jun 4;6(1):115. doi: 10.1186/s13287-015-0107-0. Stem Cell Res Ther. 2015. PMID: 26041023 Free PMC article.
-
Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. III. Subcellular distribution and interaction of 99Tc-DMS complex with macromolecules in rat kidney homogenates in vitro.Eur J Nucl Med. 1982;7(7):308-10. doi: 10.1007/BF00253426. Eur J Nucl Med. 1982. PMID: 6288383
-
Radionuclide targeting and dosimetry at the microscopic level: the role of microautoradiography.Eur J Nucl Med. 1994 Dec;21(12):1347-65. doi: 10.1007/BF02426701. Eur J Nucl Med. 1994. PMID: 7875174 Review.